The P2X7 receptor in inflammatory diseases: angel or demon?

LEB Savio, P de Andrade Mello… - Frontiers in …, 2018 - frontiersin.org
Under physiological conditions, adenosine triphosphate (ATP) is present at low levels in the
extracellular milieu, being massively released by stressed or dying cells. Once outside the …

The P2X7 receptor: central hub of brain diseases

R Andrejew, Á Oliveira-Giacomelli… - Frontiers in Molecular …, 2020 - frontiersin.org
The P2X7 receptor is a cation channel activated by high concentrations of adenosine
triphosphate (ATP). Upon long-term activation, it complexes with membrane proteins forming …

The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease

R Bartlett, L Stokes, R Sluyter, DR Sibley - Pharmacological reviews, 2014 - Elsevier
The P2X7 receptor is a trimeric ATP-gated cation channel found predominantly, but not
exclusively, on immune cells. P2X7 activation results in a number of downstream events …

P2X7 in cancer: from molecular mechanisms to therapeutics

R Lara, E Adinolfi, CA Harwood, M Philpott… - Frontiers in …, 2020 - frontiersin.org
P2X7 is a transmembrane receptor expressed in multiple cell types including neurons,
dendritic cells, macrophages, monocytes, B and T cells where it can drive a wide range of …

Irradiation causes senescence, ATP release, and P2X7 receptor isoform switch in glioblastoma

M Zanoni, AC Sarti, A Zamagni, M Cortesi… - Cell Death & …, 2022 - nature.com
Glioblastoma (GBM) is the most lethal brain tumor in adults. Radiation, together with
temozolomide is the standard treatment, but nevertheless, relapse occurs in nearly all cases …

Mechanisms of Invasion in Glioblastoma: Extracellular Matrix, Ca2+ Signaling, and Glutamate

JS So, H Kim, KS Han - Frontiers in cellular neuroscience, 2021 - frontiersin.org
Glioblastoma (GBM) is the most common and malignant form of primary brain tumor with a
median survival time of 14–16 months in GBM patients. Surgical treatment with …

P2X7 receptor as a therapeutic target

E De Marchi, E Orioli, D Dal Ben, E Adinolfi - Advances in protein chemistry …, 2016 - Elsevier
P2X7 receptor is an ATP-gated cation channel that upon agonist interaction leads to cellular
influx of Na+ and Ca 2+ and efflux of K+. P2X7 is expressed by a wide variety of cells and its …

Multifaceted effects of extracellular adenosine triphosphate and adenosine in the tumor–host interaction and therapeutic perspectives

P de Andrade Mello, R Coutinho-Silva… - Frontiers in …, 2017 - frontiersin.org
Cancer is still one of the world's most pressing health-care challenges, leading to a high
number of deaths worldwide. Immunotherapy is a new developing therapy that boosts …

Alternatively spliced isoforms of the P2X7 receptor: structure, function and disease associations

SKF De Salis, L Li, Z Chen, KW Lam… - International Journal of …, 2022 - mdpi.com
The P2X7 receptor (P2X7R) is an ATP-gated membrane ion channel that is expressed by
multiple cell types. Following activation by extracellular ATP, the P2X7R mediates a broad …

Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer

M Drill, NC Jones, M Hunn, TJ O'Brien, M Monif - Purinergic signalling, 2021 - Springer
Abstract The P2X receptor 7 (P2X7R) is a plasma membrane receptor sensing extracellular
ATP associated with a wide variety of cellular functions. It is most commonly expressed on …